Drugs / INI101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07622004 | May 2021 → Jan 2022 | — | INIBIO Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INI101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07622004 ↗ |
| Modality | Protein / enzyme biologic | “botulinum toxin type A for injection INI101” NCT07622004 ↗ |